In pathological contexts, VASH-1 exhibits paradoxical expression patterns-downregulated in neuroendocrine tumors but upregulated in bladder cancer-and demonstrates tissue-specific functions that either inhibit or promote angiogenesis. Here, VASH1 is linked to urinary bladder carcinoma.